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When unfolded proteins accumulate to irremediably
high levels within the endoplasmic reticulum (ER),
intracellular signaling pathways called the unfolded
protein response (UPR) become hyperactivated
to cause programmed cell death. We discovered
that thioredoxin-interacting protein (TXNIP) is a
critical node in this ‘‘terminal UPR.’’ TXNIP becomes
rapidly induced by IRE1a, an ER bifunctional kinase/
endoribonuclease (RNase). Hyperactivated IRE1a
increases TXNIP mRNA stability by reducing levels
of a TXNIP destabilizing microRNA, miR-17. In turn,
elevated TXNIP protein activates the NLRP3 inflam-
masome, causing procaspase-1 cleavage and inter-
leukin 1b (IL-1b) secretion. Txnip gene deletion
reduces pancreatic b cell death during ER stress
and suppresses diabetes caused by proinsulin
misfolding in the Akita mouse. Finally, small mole-
cule IRE1a RNase inhibitors suppress TXNIP
production to block IL-1b secretion. In summary,
the IRE1a-TXNIP pathway is used in the terminal
UPR to promote sterile inflammation and pro-
grammed cell death and may be targeted to develop
effective treatments for cell degenerative diseases.
INTRODUCTION
The endoplasmic reticulum (ER) is the first organelle that proteins
of the secretory pathway encounter as they mature structurally250 Cell Metabolism 16, 250–264, August 8, 2012 ª2012 Elsevier Incand fold to their native conformations (Gething and Sambrook,
1990). Cells specialized for secretion, such as insulin-producing
pancreatic islet b cells, accommodate a high rate of cargo
proteins transiting through the ER (Scheuner and Kaufman,
2008). But when conditions demand that these cells further
increase protein secretion, the secretory pathway can quickly
become overwhelmed. Inability to properly fold large secretory
loads causes accumulation of unfolded proteins within the ER.
In cells experiencing such ‘‘ER stress,’’ intracellular signaling
pathways termed the unfolded protein response (UPR) become
activated. Upon detecting unfolded proteins, three ER trans-
membrane sensors—IRE1a, PERK, and ATF6—initiate the
UPR pathways (Harding et al., 1999; Tirasophon et al., 1998;
Yoshida et al., 1998). Combinatorial signals from the three
sensors increase transcription of target genes encoding ER
chaperones and enzymatic activities, thus enhancing folding
and maturation of secretory proteins. UPR targets also allow
unfolded proteins to be extracted from the ER, and subsequently
degraded in the cytosol (a process called ER-associated degra-
dation) (Vembar and Brodsky, 2008). Additionally, a transient
reduction in translation relieves ER protein load (Harding et al.,
2001). If these adaptive UPR outputs are successful, the decline
in unfolded proteins causes UPR signaling to wane as homeo-
stasis is restored (Merksamer et al., 2008).
Alternatively, cells may experience ER stress at levels that are
high—or prolonged—enough to overwhelm adaptive responses.
Such irremediable ER stress can result from genetic mutations
causing improper folding or modification of encoded secretory
proteins. A well-studied example is the unoxidizable mutant
form of murine proinsulin—called Akita—that cannot form an
intramolecular disulfide bond needed to fold in the ER. Buildup
of Akita in b cells triggers programmed cell death, leading to
a dominantly inherited form of diabetes in the mutant mice.
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causing mutations in the proinsulin gene occur in humans
(Støy et al., 2007). Irremediable ER stress can also be caused
by pharmacologically inhibiting important ER protein modifica-
tion processes. Under chronic and uncorrected ER stress,
a terminal UPR becomes activated to trigger programmed cell
death (Merksamer and Papa, 2010; Shore et al., 2011). Multicel-
lular organisms may have evolved the ability to cull irremediably
stressed cells through programmed cell death in order to prevent
production of improperly modified or misfolded proteins. How-
ever, massive cell loss, which goes unmatched by cell prolifera-
tion, can lead to cell degenerative diseases.
Programmed cell death during chronic/high ER stress is an
active process and is promoted by alternate outputs of the
UPR itself, which bias cell fate away from adaptation to the
opposite extreme of cell destruction (Han et al., 2009). As activa-
tion levels of IRE1a, PERK, and ATF6 reflect either an adapted
ER, or the continued presence of unfolded proteins, these
upstream sensors are centrally poised to participate in the
switching process between adaptation and destruction. How-
ever, many other key downstream links in this switching process
remain to be discovered, and their elucidation may provide
inroads to treat diseases of cell loss.
To find undiscovered signaling mediators of a terminal UPR,
we conducted an unbiased screen to discover messenger
RNAs (mRNAs) whose translation increases during irremediable
ER stress. Through this strategy, we identified thioredoxin-inter-
acting protein—TXNIP—as a critical node in a chain of destruc-
tion leading from the ER to programmed cell death. Remarkably,
IRE1a utilizes a microRNA intermediate to control induction of
TXNIP mRNA. Induced TXNIP protein in turn activates the
NLRP3 inflammasome to cleave procaspase-1 to its active
form, thereby causing maturation and secretion of the inflamma-
tory cytokine, IL-1b. Furthermore, we find that TXNIP action is
critical for programmed cell death of pancreatic b cells under
ER stress in vivo, and development of diabetes in rodents.
Finally, our work provides pharmacological insights to target
this destructive UPR chain at its upstream source, IRE1a, and
thereby preserve cell viability and function.
RESULTS
Thioredoxin-Interacting Protein Is Rapidly Induced
through the UPR
To identify signaling proteins mediating UPR-induced cell
destruction, we purified polyribosomes to enrich for mRNAs
that become preferentially translated (Heiman et al., 2008) very
early in response to catastrophic ER stress. A gene encoding
an enhanced green fluorescent protein (EGFP) epitope target
was fused to the large ribosomal subunit protein L10a, and
expressed in INS-1 insulinoma cells, which are differentiated
insulin-producing cells derived from rat pancreatic islets (Fig-
ure 1A). The chimeric gene (or an EGFP control) was driven
from a tetracycline-inducible expression construct integrated
at a chromosomal FRT docking site in the INS-1 cells. Exposed
to doxycycline (Dox), the cells express the EGFP-L10a fusion, or
EGFP (Figure 1B). Compared to EGFP, which localizes primarily
to the cytosol, EGFP-L10a localizes to both cytosol and nucleo-
somes, consistent with assembly into ribosomes (Figure 1C)Cel(Heiman et al., 2008). Immunoaffinity purification (using anti-
EGFP antibodies) of ribosomes in cells expressing EGFP-L10a
was confirmed by detecting a different ribosomal protein, L7
(Figure 1D). After inducing EGFP-L10a INS-1 cells with Dox,
we treated them with the ER stress agent thapsigargin (Tg),
which inhibits the SERCA (sarcoplasmic-endoplasmic reticulum
calcium ATPase) pump, at a concentration (1 mM) known to
trigger apoptosis in the entire population by 24 hr (Han et al.,
2009). To reveal proteins translated very early under this regime
of irremediable ER stress, we treated the cells with Tg for just
30 min before isolating mRNA from either immunoaffinity-
purified polyribosomes or total mRNA; both sources of RNA
were used to perform comparative DNAmicroarray analysis (Fig-
ure 1E). Validating our approach, Ddit3, a proapoptotic UPR
transcription factor also known as CHOP, was identified in the
hit list of 38 genes with a 2-fold or greater change in expression
in both total and affinity-purified mRNA (Table S1 available
online). CHOP is known to be both transcriptionally and transla-
tionally upregulated in the UPR (Jousse et al., 2001; Palam
et al., 2011).
Of other significantly induced genes on the list, we focused our
attention on thioredoxin-interacting protein (TXNIP). TXNIP was
first described as a binding partner of thioredoxin that regulates
its antioxidant functions (Nishiyama et al., 1999; Patwari et al.,
2006; Yamanaka et al., 2000). As TXNIP had been implicated
in glucotoxicity-induced apoptosis of b cells (Chen et al., 2008;
Shalev, 2008), we reasoned that it may also mediate pro-
grammed cell death in response to ER stress; therefore, we
embarked on experiments to investigate the underlying mecha-
nisms and physiology of this putative link.
TXNIP induction is evident in microarrays using both total and
polysome-associated mRNA. From parent INS-1 cells exposed
to 1 mM Tg, northern blots and quantitative PCR show that total
TXNIP mRNA increases by 10-fold within 2 hr (Figures 1F and
1G). Treatment with the ER stress agent tunicamycin (Tm), an
inhibitor of N-linked glycosylation, also increases TXNIP mRNA
(Figure 1H). Validating our immunoaffinity purification strategy,
we fractionated ribosomes according to size, and we found,
using yet another mediator of ER stress, the anterograde protein
trafficking poison Brefeldin A (BFA), an approximately 50-fold
migration of TXNIP mRNA from monosomes (in the uninduced
state) to polysomes (Figure 1I).
As a consequence of strong recruitment of its mRNA to poly-
somes, TXNIP protein becomes rapidly and robustly translated
under ER stress (Figures 1J and 1K). Rapid, high-level induction
of TXNIP under ER stress is reminiscent of its induction under
high ambient glucose (Figures S1A–S1C) (Shalev et al., 2002).
TXNIP was previously found to be induced by oxidant stress
(e.g., H2O2) (Zhou et al., 2010), but we found that it also becomes
induced upon exposure to the cell-permeable reductant dithio-
threitol (DTT), which reduces disulfide bonds in the ER to cause
protein misfolding (Figures S1D and S1E). Taken together, these
data demonstrate that diverse perturbations in ER protein folding
cause robust and rapid induction of the Txnip gene, at both the
mRNA and protein level.
The UPR sensors IRE1a, PERK, and ATF6 become activated
as the earliest signaling events in cells experiencing ER stress.
Because TXNIP is induced contemporaneously with PERK and
IRE1a activation (Figure S2A), we reasoned that early UPRl Metabolism 16, 250–264, August 8, 2012 ª2012 Elsevier Inc. 251
Figure 1. TXNIP mRNA and Protein Are Rapidly Induced in Cells Undergoing Endoplasmic Reticulum Stress
(A) Schematic of affinity purification of polyribosomes using a translational fusion of enhanced green fluorescent protein (EGFP) to the large ribosomal subunit
protein L10a (EGFP-L10a).
(B) Immunoblot analysis of whole-cell extracts from 24 hr untreated and 1 mg/ml doxycycline (Dox)- treated insulinoma (INS-1) cell lines expressing EGFP, or
a EGFP translational fusion to the large ribosomal subunit protein L10a (EGFP-L10a) under a Dox inducible promoter.
(C) Confocal images of INS-1 cells expressing EGFP or EGFP-L10a. Prior to imaging, cells were induced with 1 mg/ml Dox for 24 hr, fixed with paraformaldehyde,
and stained with 40,6-diamidino-2-phenylindole (DAPI).
(D) Immunoblot analysis of ribosomal protein L7 (RPL7) after anti-EGFP immunoprecipitation (IP) confirms coimmunoprecipitation of ribosomes in INS-1 cells
expressing EGFP-L10a (but not in cells expressing EGFP) after 24 hr treatment with 1 mg/ml Dox.
(E) Hierarchical clustering analysis of gene expression changes in INS-1 EGFP-L10a-expressing cells (Dox 1 mg/ml for 24 hr) under ER stress through the use of
DNA microarrays. Complementary RNAs (cDNAs) for hybridization were generated from total cellular mRNAs, or from mRNAs collected from anti-EGFP-L10a
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protein. To test this, we treated mouse embryonic fibroblasts
(MEFs) deficient for each UPR sensor with either Tm or Tg (Fig-
ure 2A). TXNIP mRNA induction is significantly diminished in
both Ire1a/ and Perk/MEFs during ER stress, but induction
remains unperturbed in Atf6a/ MEFs. Paralleling this effect,
TXNIP protein induction is completely abrogated in Ire1a/
and Perk/ MEFs during ER stress (Figure 2B), but unaffected
in Atf6a/ MEFs (Figure S3A).
IRE1a and PERK are two different ER transmembrane proteins
that homo-oligomerize through an ER lumenal domain that
senses unfolded proteins (Arago´n et al., 2009; Credle et al.,
2005; Gardner and Walter, 2011; Zhou et al., 2006). Both ER
stress sensors have serine/threonine kinase activities on their
cytosolic face. For both PERK and IRE1a, homo-oligomerization
of ER lumenal domains juxtaposes their respective cytosolic
kinase domains, and they consequently trans-autophosphory-
late. For PERK, trans-autophosphorylation is a potentiating
step that causes the kinase to subsequently phosphorylate the
translation initiation factor, eIF2a, causing translational attenua-
tion. We noted that forced dimerization using a chemical dimer-
izer of a FK506 binding protein-PERK eIF2a kinase construct is
sufficient to induce TXNIP mRNA, without upstream ER stress
(Figures S3B and S3C).
IRE1a is themore ancient of the two UPR sensors, and in addi-
tion to its kinase catalytic activity it contains an endoribonu-
clease (RNase) at its C-terminal end (Wang et al., 1998). For
IRE1a, trans-autophosphorylation is a potentiating step that acti-
vates its RNase to initiate splicing of the mRNA encoding the
XBP1 transcription factor. IRE1a-mediated splicing of XBP1
mRNA removes a 26 nucleotide intron and alters the open
reading frame (ORF); translated in the alternate ORF, spliced
XBP1 mRNA encodes the XBP1s (s, spliced) transcription factor
whose target genes enhance ER protein folding capacity (Fig-
ure S2B) (Calfon et al., 2002; Lee et al., 2003; Yoshida et al.,
2001). Thus, by splicing XBP1 mRNA, IRE1a’s RNase promotes
adaptation to ER stress. However, under irremediable ER stress,
IRE1a’s RNase becomes hyperactive and causesmassive endo-
nucleolytic degradation of ER-localized mRNAs and down-
stream c-Jun N-terminal kinase (JNK) phosphorylation to
promote apoptosis (Han et al., 2009). Therefore, we decided to
study if IRE1a uses TXNIP as an intermediary to trigger cell death
under irremediable ER stress.
We previously developed tools through which we can forcibly
activate IRE1a at will. Because IRE1a naturally activates through
self-association in the ER membrane under ER stress, we can
mimic this step by conditionally overproducing the protein from
a transgene. In this situation, the transgenic IRE1a protein
self-associates by mass action, without requiring upstream ERaffinity-purified ribosomes. Indicated genes are those whose expression increas
30 min (compared to no treatment). See Table S1 for gene identities, log2 expres
(F and G) Time course analysis of TXNIP mRNA expression (normalized to GAPD
real-time PCR (qPCR) (G).
(H) Analysis of TXNIP mRNA expression (normalized to GAPDH) during ER stres
(I) Polyribosome profiling demonstrates recruitment of TXNIP mRNA from monos
30 min.
(J) Immunoblot detection of TXNIP protein in INS-1 cells during ER stress (1 mM
(K) Immunoblot detection of TXNIP protein in INS-1 cells during ER stress (5 mg/m
Data are shown as mean ± SD. **p < 0.005. See also Figures S1 and S2.
Celstress. Thus, unlike pleiotropic ER stress-inducing agents that
activate all arms of the UPR, our tools allow us to delineate the
specific contribution of IRE1a to any UPR-linked physiological
process. We decided to employ these tools to study the
contribution of IRE1a’s catalytic activities to TXNIP induction
(Figure 2C).
Expression of transgenic WT IRE1a (using Dox) causes the
protein to spontaneously autophosphorylate as it accumulates
(Figure 2E); this leads to complete conversion of cellular XBP1
mRNA to the spliced form (Figure S4C), as occurs under ER
stress (Figure S2A) (Han et al., 2009). Activation of WT IRE1a
through this maneuver is sufficient to induce TXNIP mRNA
(Figures 2D and S4E) and protein (Figure 2F).
To dissect the effects of IRE1a’s catalytic activities on TXNIP
upregulation, we tested two point mutants. The first, IRE1a
(I642G), has an enlarged adenosine triphosphate (ATP)-binding
pocket in its kinase domain that destroys phosphotransfer cata-
lytic activity; the enlarged pocket can selectively bind 1NM-PP1,
a cell-permeable adenosine nucleotide mimic with a bulky
chemical head group (Figure 2C) (Han et al., 2008; Papa et al.,
2003). Binding of 1NM-PP1 to IRE1a (I642G) allosterically acti-
vates the RNase domain, causing it to forcibly splice XBP1
mRNA, while bypassing the autophosphorylation requirement
(Figures S4B and S4C). A second mutant, IRE1a (N906A), can
properly autophosphorylate when expresssed, but because its
RNase active site is mutated cannot splice XBP1 mRNA (Figures
2C, 2F, and S4C). Interestingly, expression of IRE1a (N906A)
leads to small, reproducible decreases in basal TXNIP mRNA
(Figures 2D and S4E) and protein (Figure 2F), consistent with
its known dominant-negative effects against endogenous
IRE1a. Furthermore, induction of either IRE1a (I642G)—or forced
expression of spliced XBP1 transcription factor (XBP1s)—cause
minimal elevation of TXNIP mRNA, without discernible changes
in TXNIP protein (Figures 2D–2G). These results argue that
robust TXNIP induction requires both functional kinase and
RNase catalytic activities of IRE1a and is largely independent
of XBP1 transcription factor activity. This last point was
confirmed using Xbp1/ MEFs, in which production of TXNIP
under ER stress is intact (Figure S3D). Indeed, TXNIP protein is
detectable in Xbp1/ MEFs even under basal conditions,
consistent with a previous observation that in the absence of
XBP1, IRE1a becomes partially activated even without ER stress
(Lee et al., 2008). In contrast, induction of TXNIP under ER stress
is abrogated in Jnk1,2/MEFs (Figure S3E), arguing that TXNIP
regulation by IRE1a occurs downstream of JNK.
IRE1a Utilizes a MicroRNA to Control TXNIP Levels
Transcriptional stimulation of TXNIP mRNA in response to
increased glucose has been previously studied (Cha-Molstaded (red) or decreased (green) at least 2-fold under 1 mM thapsigargin (Tg) for
sion changes, and statistics.
H) during ER stress (1 mM Tg) in INS-1 cells by Northern blot (F) or quantitative
s with 5 mg/ml tunicamycin (Tm) or 1 mM Tg in INS-1 cells by qPCR.
omes into polyribosomes under treatment with 2.5 mg/ml brefeldin A (BFA) at
Tg).
l Tm). Three independent biological samples were used for qPCR experiments.
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Figure 2. Robust Induction of TXNIP Requires Activation of IRE1a’s Bifunctional Kinase and RNase Domains
(A) Analysis of TXNIP mRNA expression (normalized to GAPDH) by qPCR during ER stress treatment in UPR sensor signaling mutants. Atf6a/, Perk/, and
Ire1a/ MEFs (and wild-type counterparts) were treated with 1 mM Tg, or 5 mg/ml Tm, for 6 hr.
(B) Immunoblot for TXNIP protein from whole-cell lysates of wild-type, Ire1a/, and Perk/ MEFs untreated or treated with 1 mM Tg or 5 mg/ml Tm for 3 hr.
(C) Schematic representation of IRE1a variants used in this study, and chemical structure of 1NM-PP1.
(D) Time-course analysis of TXNIP mRNA expression (normalized to GAPDH) by qPCR through ER stress-independent forcible activation of IRE1a and mutants,
and forced expression of XBP1s, in INS-1 cells with 1 mg/ml Dox and 5 mM 1NM-PP1.
(E) Time-course analysis of TXNIP proteins (by immunoblot) following forced activation of IRE1a and mutants, and forced expression of XBP1s, in INS-1 cells
untreated or treated with 1 mg/ml Dox and 5 mM 1NM-PP1.
Three independent biological samples were used for qPCR experiments. Data are shown as mean ± SD. **p < 0.005, *p < 0.01. See also Figures S3 and S4.
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IRE1a Induces TXNIP, Inflammasome, and Cell Deathet al., 2009; Yu and Luo, 2009). In response to elevated glucose
levels, the transcription factor carbohydrate response element-
binding protein (ChREBP) interacts with a consensus element in
the TXNIP promoter to increase TXNIP transcription (Yu and
Luo, 2009). We noted that ChREBP translocates to the nucleus
and binds TXNIP promoter elements under ER stress (Figures
S5A and 5B). Furthermore, under ER stress, ChREBP mRNA
itself increases about 2-fold (Figure S5C). Luciferase reporter
constructs containing variable TXNIPpromoter regions, including
two carbohydrate response elements (ChoREs) are activated in
response to ER stress, but activation of the reporter constructs
was never greater than about 2-fold, in contrast to the robust
induction that occurs under hyperglycemia (Figures S5D–S5F).
Thus, while some contribution of de novo TXNIP transcription
can be traced to known cis (ChORE) and trans (ChREBP)
elements (Figures S5G–S5I), transcriptional activation is signifi-
cantly weaker than under hyperglycemia, and hence insufficient
to account for the robust increases in TXNIP mRNA to their new
steady-states under ER stress. This implied either the existence
of unidentified trans factors and/or cis elements that stimulate
TXNIP transcription under ER stress, or that the induction is
alsodue toprocessesother than transcription. To test this second
possibility, we asked whether the rapid induction of TXNIP upon
ER stress is due in part to changes in mRNA stability. By
measuring mRNA half-life when transcription is arrested by Acti-
nomycin D (ActD), we find that TXNIP mRNA is inherently labile,
but that it becomes significantly stabilized (3-fold) during ER
stress (Figures 3A and 3B).
mRNA stability is often governed by binding of specific micro-
RNAs to complementary sequences in the 30 untranslated region
(UTR) of gene targets (Fabian et al., 2010). Bioinformatic analysis
of the TXNIP 30 UTR identified two conserved binding sites for
microRNA-17 (miR-17) (Figure 3C). This provoked the hypoth-
esis that changes in miR-17 may regulate TXNIP mRNA stability.
Consistent with this notion, we find that miR-17 levels rapidly
decline under ER stress, but not under high glucose (Figure 3D).
TXNIPmRNA levels can be increased by introducing anti-miR-17
into cells (Figure 3E); conversely, a miR-17 mimic reduces base-
line levels of TXNIP mRNA (Figure 3F).
Wenext used heterologous reporter systems to test the conse-
quence of miR-17 reduction. We constructed a mCherry, red
fluorescent protein (RFP) reporter that contains tandem miR-17
seed sequences in its 30 UTR; the reporter is designed to express
RFP when cellular miR-17 levels drop. Upon transfection into
wild-type MEFs, the reporter becomes derepressed under ER
stress to produce RFP, indicating reduction in endogenous
miR-17 (Figure 3G). The reporter remains silenced in Ire1a/
MEFs, indicating that IRE1a is necessary for reduction of miR-
17 under ER stress. To further investigate whether IRE1a is suffi-
cient for miR-17-dependent control of TXNIP, we constructed
a luciferase reporter containing the entire TXNIP 30 UTR, and
a versionmutated in themiR-17 seed sequences. Upon transfec-
tion of these reporters into Dox-inducible WT-IRE1a cells (Fig-
ure 2C), induction with Dox increases baseline luciferase activity
driven from the wild-type—but not themiR-17mutant—TXNIP 30
UTR reporter (Figure 3H). Together, these results argue that acti-
vation of IRE1a increases TXNIP mRNA levels posttranscription-
ally by reducing its inhibitory microRNA, miR-17. Rationalizing
our results, a mathematical model (Figures S5J and S5K) showsCelthat a combination of transcriptional and posttranscriptional
control of TXNIP mRNA produces a sharper—and more rapid—
rise to new steady-state levels upon ER stress than would occur
through de novo mRNA synthesis alone.
Txnip Deletion Protects against ER Stress-Induced
b Cell Programmed Cell Death and Diabetes
We next explored the physiological connection of TXNIP to ER
stress-mediated cell degeneration and disease. Given that the
loss of TXNIP protects against glucotoxicity, we tested whether
it would similarly protect cells against ER stress-induced pro-
grammed cell death. To this end, we challenged Txnip/
MEFs with ER stress agents and found that they are strikingly
resistant to programmed cell death (Figure 4A), despite the
fact that adaptive UPR outputs—XBP1 mRNA splicing and tran-
scriptional induction of the ER chaperone BiP—are no different
than in Txnip+/+ MEFs (Figures S6A and S6B). As with cell lines,
freshly harvested pancreatic islets from wild-type C57BL/6 mice
induce TXNIP mRNA under Tm (Figure 4B). However, b cells in
pancreatic islets from Txnip/ mice are strongly protected
(compared to Txnip+/+ mice) from programmed cell death under
Tm (Figures 4C and 4D).
Considering the substantial cytoprotection enjoyed by
Txnip/ MEFs and islets against pharmacological inducers of
ER stress, we next tested whether loss of TXNIP would amelio-
rate b cell degeneration and development of diabetes in the
Ins2WT/C96Y—‘‘Akita’’—mouse. Because INS2 (C96Y) proinsulin
cannot form a critical intramolecular disulfide bond needed to
fold in the ER, it accumulates as a proteotoxin that causes ER
stress-induced b cell loss and spontaneous diabetes during
infancy (Oyadomari et al., 2002; Ron, 2002). Ins2WT/C96Y mice
begin developing hyperglycemia at approximately 3 weeks of
age, but are not frankly diabetic and can still dispose of a glucose
load by glucose tolerance test (GTT) (Figure S6E). However, even
at 3 weeks, islets from Ins2WT/C96Y mice display significantly
elevated baseline IRE1a activation (2-fold increased XBP1
mRNA splicing), documenting elevated ER stress prior to devel-
opment of frank diabetes (Figure 5A). Furthermore, the IRE1-
a-TXNIP pathway is also activated in islets from Ins2WT/C96Y
mice at 3 weeks of age, as evidenced by significantly decreased
miR-17 levels and elevated TXNIP mRNA expression at baseline
(Figures 5B and 5C).
We then crossed the Txnip/ and Ins2WT/C96Y mice and
followed b cell apoptosis and development of diabetes in the
various cohorts. While the different cohorts have no significant
differences in body weight over time (Figure 5D), Txnip/;
Ins2WT/C96Y mice are strikingly protected from hyperglycemia
compared to Txnip+/+; Ins2WT/C96Ymice, for up to 12 weeks (Fig-
ure 5E). Moreover, Txnip/; Ins2WT/C96Y islets display signifi-
cantly lower levels of b cell apoptosis compared to islets from
Txnip+/+; Ins2WT/C96Y mice (Figures 5F and 5G), confirming that
TXNIP plays a critical role in promoting programmed b cell death
in this spontaneous ER stress model of diabetes.
Blocking TXNIP Induction and IL-1b Secretion through
Small Molecule Inhibition of IRE1a
We next explored the mechanistic bases of TXNIP-mediated cell
death by turning our attention to the NLRP3 inflammasome. The
NLRP3 inflammasome is a multiprotein complex that sensesl Metabolism 16, 250–264, August 8, 2012 ª2012 Elsevier Inc. 255
Figure 3. IRE1a Increases TXNIP mRNA Stability through Decreasing miR-17
(A and B) Analysis by northern blotting and qPCR shows that TXNIP mRNA is short lived but becomes stabilized under ER stress. Total RNA extracts from INS-1
cells treated with 5 mg/ml Actinomycin D plus/minus 1 mMTgwere probed for TXNIPmRNA (or GAPDH). Early time course (first hour) qPCR of TXNIPmRNA levels
(relative to GAPDH) in INS-1 cells treated with 5 mg/ml Actinomycin D plus/minus 1 mM Tg with best fit line (B).
(C) Schematic showing miR-17 binding sites within the 30 UTR of TXNIP mRNA across multiple species.
(D) qPCR of miR-17 levels from HEK293 cells untreated or treated with 1 mM Tg, or 5 mg/ml Tm, for 6 hr.
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Figure 4. Loss of Txnip Protects MEFs and
Pancreatic Islets against ER Stress-Induced
Apoptosis
(A) Wild-type and Txnip/ MEFs were challenged
with 1 mM Tg or 5 mg/ml Tm for 24 hr and assessed
for apoptosis by flow cytometry for Annexin-V
binding.
(B) Pancreatic islets were isolated from 6-week-old
C57BL/6 mice and left untreated or treated with
1 mM Tg for 6 hr. TXNIP mRNA (relative to GAPDH)
was measured by qPCR.
(C) Pancreatic islets were isolated from 6-week-old
Txnip+/+ and Txnip/ mice, cultured in the
absence or presence of 5 mg/ml Tm for 12 hr, and
then subjected to DAPI, anti-insulin, and TUNEL
staining.
(D)QuantificationofTUNEL-positivebcells from (C).
Bar graphs represent three independent biological
samples. All mice were on C57BL/6 genetic
background. Data are shown as mean ± SD.
**p < 0.005. See also Figure S6.
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IRE1a Induces TXNIP, Inflammasome, and Cell Deathendogenous ‘‘danger’’ signals—also called damage associated
molecular pattern molecules (DAMPs)—and leads to maturation
and secretion of the proinflammatory cytokine, interleukin-1
b (IL-1b) (Strowig et al., 2012). TXNIP was recently discovered
to bind and activate the NLRP3 inflammasome, and murine(E) TXNIP mRNA levels as analyzed by qPCR from HEK293 cells 24 hr posttransfection with scrambled or m
(F) TXNIP mRNA levels as analyzed by qPCR from HEK293 cells 24 hr posttransfection with scrambled or m
(G) Immunoblot analysis of miR-17 mCherry sensor in wild-type and Ire1a/MEFs (36 posttransfection) afte
(H) IRE1a induction of TXNIP luciferase reporter is dependent on miR-17 binding sites. Dox-inducible WT-
a luciferase reporter construct containing wild-type or miR-17 binding mutant TXNIP 30 UTR. The cells were t
lysed and then analyzed for luciferase activity.
Three independent biological samples were used for qPCR and luciferase experiments. Data are shown as m
Figure S5.
Cell Metabolism 16, 250–2Txnip/ islets are resistant to glucose-
induced NLRP3 inflammasome activation
and IL-1b secretion (Zhou et al., 2010).
Having connected ER stress to
production of TXNIP, we specifically
tested whether ER stress also causes
production of IL-1b. Indeed, we find that
Tg causes robust IL-1b secretion, as
occurs during hyperglycemia in pancre-
atic islets (Figure 6A), or extracellular
ATP, a well-known DAMP and NLRP3 in-
flammasome activator, in THP-1 macro-
phage cell lines (Figure 6B). We further
tested known signaling events linking
activation of the NLRP3 inflammasome
to IL-1b production by DAMPs,
and found that ER stress causes cas-
pase-1 cleavage from its zymogen form,
as occurs with ATP (Figure 6C). The
effects of ER stress on IL-1b appear to
be largely posttranscriptional as only
modest increases of IL-1b mRNA occur
with Tg (Figure S7G). Furthermore, short
hairpin RNA knockdown of the NLRP3 in-flammasome abrogates caspase-1 cleavage, and IL-1b produc-
tion, under ER stress (Figures 6D and 6E), as does a specific
inhibitor of caspase-1, Z-YVAD-FMK (Figures S7H and S7I).
Finally, we reasoned that because IRE1a controls TXNIP
induction, we may be able to reduce TXNIP and IL-1b byiR-17 anti-miR.
iR-17 mimic.
r treatment with DMSO control or 1 mM Tg for 12 hr.
IRE1a HEK293 cells were transfected (24 hr) with
reated with DMSO control or 1 mg/ml Dox for 24 hr,
ean ± SD. **p < 0.005; ns, not significant. See also
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Figure 5. Txnip Deficiency Protects against b Cell Loss and Diabetes in the Ins2WT/C96Y Mouse
(A–C) Pancreatic islets from 3-week-old Ins2WT/C96Y mice show evidence of ER stress at baseline, including increased XBP-1 splicing, decreased miR-17, and
elevated TXNIP mRNA as assessed by qPCR.
(D) Indicated genotypes showed no significant differences in body weight up to 12 weeks of age. For the 12 week timecourse, n = 9 for Txnip+/+Ins2WT/C96Ymice,
n = 10 for Txnip+/+Ins2WT/WT, and n = 8 for both Txnip/Ins2WT/WT and Txnip/Ins2WT/C96Ymice.
(E) Body glucose levels for the indicated genotypes up to 12 weeks of age. Note that Txnip/Ins2WT/C96Y mice have significantly lower blood glucose levels
compared to Txnip+/+Ins2WT/C96Y mice at all time points.
(F) Pancreatic islets were isolated from mice of the indicated genotypes at 5 weeks of age and assessed by DAPI, anti-insulin, and TUNEL staining.
(G) Quantification of TUNEL-positive b cells from experiments in (F).
Bar graphs represent three independent biological samples. All mice were on C57BL/6 genetic background. Data are shown as mean ± SD. **p < 0.005. See
also Table S2.
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Cell Metabolism
IRE1a Induces TXNIP, Inflammasome, and Cell Deathinhibiting IRE1a with small molecules. Recently, a cell-perme-
able small molecule—called STF-083010—capable of cova-
lently inhibiting IRE1a RNase was described (Papandreou
et al., 2011). We resynthesized STF-083010 and tested its ability
to prevent IRE1a activation. Figure 6F shows complete inhibition
of IRE1a-mediated XBP1 mRNA splicing by STF-083010 when
provided to cells before exposure to Tm. Note that treatment
with ATP does not trigger ER stress, as evidenced by unchanged
XBP1 mRNA splicing, but interestingly, STF-083010 can reduce
basal levels of XBP1 mRNA splicing even in the ATP-treated
cells. Strikingly, STF-083010 pretreatment prevents production
of TXNIP under forcible IRE1a activation (Figure 6G). Further-
more, provision of STF-083010 effectively shuts off secretion
of IL-1b during treatment with Tg, but not ATP (Figure 6H). This
indicates that ER stress signals to the NLRP3 inflammasome
can be specifically blocked by a small molecule targeting the
proximal UPR sensor, IRE1a, while still allowing other DAMP
signals to be relayed.
DISCUSSION
TXNIP Is a Signaling Hub through which Cells Respond
to Irremediable ER Stress
Cells expend considerable resources to maintain secretory
homeostasis when ER stress levels fall within containable limits.
Paradoxically when ER stress levels rise above critical thresh-
olds, cells actively commit to programmed cell death. Robust
signaling networksmay force cells to make such a binary choice.
We predicted the existence of signaling proteins that mediate
destructive responses to catastrophic ER stress and sought to
discover such proteins using unbiased screens. Using a strategy
to identify translational targets of the UPR (which was historically
described and studied as a transcriptional pathway), we identi-
fied TXNIP as a critical mediator of cell death in response to cata-
strophic ER stress—a process we refer to as a terminal UPR.
TXNIP gene regulation is robustly wired into the terminal UPR.
TXNIP upregulation occurs rapidly when cells experience ER
stress acutely at irremediable levels. Alternatively, chronic low-
level ER stress in b cells (e.g., due to Akita proinsulin) also
increases TXNIP basal levels. While we discovered TXNIP as
a translational target, its mRNA levels also climb greater than
tenfold within 2 hr in a terminal UPR. Contemporaneously, TXNIP
mRNA becomes loaded onto polyribosomes to begin transla-
tion. Intriguingly, the new steady-state level of TXNIP mRNA
under ER stress is achieved through mRNA stabilization
combined with de novo transcription. We found that TXNIP
mRNA is inherently unstable, reminiscent of CHOPmRNA, which
encodes a proapoptotic UPR transcription factor (Rutkowski
et al., 2006). Furthermore, through a regulated event, TXNIP
mRNA becomes stabilized under ER stress. Master regulatory
proteins controlling switching into different cell states are often
encoded by short-livedmRNAs, thus ensuring rapid interconver-
sion of cell states. It is conceivable that other master regulators
of the terminal UPR are encoded by short-lived mRNAs.
TXNIP mRNA stability during ER stress is under control of
a specific microRNA, miR-17. miRs control gene expression at
posttranscriptional levels by destabilizing target mRNAs and/or
by repressing translation. Highly conserved seed sequences
for miR-17 in the TXNIP 30 UTR were found to govern posttran-Celscriptional regulation of TXNIP mRNA under ER stress. Further-
more, steady-states levels of TXNIP mRNA could be predictably
modulated: either down with a miR-17 mimic, or up with anti-
miR-17. Forcible activation of IRE1a is sufficient to decrease
cellular miR-17 levels, and endogenous IRE1a is necessary to
decrease miR-17 under irremediable ER stress.
Opposite to its effects on miR-17, forcible activation of IRE1a
is sufficient to induce TXNIP mRNA, even without ER stress, and
endogenous IRE1a is necessary for TXNIP induction under irre-
mediable ER stress. Thus, a parsimonious interpretation holds
that IRE1a controls TXNIPmRNA levels—in part—posttranscrip-
tionally by regulating levels of its repressive miR-17. We are
investigating whether decreases in miR-17 proceed directly
from endonucleolytic cleavage by IRE1a RNase, as we found
for decay of ER-localized mRNAs (Han et al., 2009).
TXNIP was previously identified as a transcriptional target of
the ChREBP transcription factor in response to elevated carbo-
hydrate and adenosine nucleotides (Minn et al., 2005; Yu and
Luo, 2009). While significant, ChREBP has a modest effect on
TXNIP transcription under ER stress: ChREBP undergoes
nuclear translocation andChREBPmRNA increases slightly (Fig-
ure S5). ER stress may overlap with hyperglycemic signals that
activate ChREBP; intriguingly, IRE1a is also partially activated
by adenosine nucleotides or hyperglycemia (Lipson et al.,
2006). An accompanying manuscript from Fumihiko Urano’s
lab in this issue of Cell Metabolism also explores PERK and
ChREBP transcriptional control of TXNIP, whichmay be comple-
mentary to IRE1a’s posttranscriptional control (Oslowski et al.,
2012). Combining posttranscriptional mRNA stabilization with
transcriptional synthesis may allow cells to robustly and rapidly
commit to self-destruction under high ER stress. Control of
gene expression under ER stress through micro RNAs may be
widespread, as in other biological processes.
Physiological Effects of TXNIP and Small-Molecule
Modulation through IRE1a
TXNIP action has been implicated in diverse physiological and
pathological contexts. TXNIP was first described as an inhibitor
of thioredoxin, an antioxidant enzyme that catalyzes cysteine-
thiol disulfide exchange (Nishiyama et al., 1999; Patwari et al.,
2006; Yamanaka et al., 2000). Increased TXNIP levels render
cells susceptible to oxidative stress. Thus, we predicted, and
confirmed, that increasing TXNIP levels would generate reactive
oxygen species (ROS); we further predicted, and confirmed, that
IRE1a hyperactivation, or irremediable ER stress, would also
spontaneously generate ROS (Figures S7A–S7F). As ROS
enhance activation of NLRP3 inflammasome, they may further
amplify effects of the IRE1a-TXNIP node to increase sterile
inflammation.
TXNIP levels are elevated in the muscle of diabetic humans
and mice (Parikh et al., 2007), and TXNIP-deficient mice have
increased adiposity while remaining insulin sensitive (Hui et al.,
2004). TXNIP is strongly induced in response to glucotoxicity,
and promotes apoptosis of b cells (Chen et al., 2008; Shalev,
2008). A recent study linked glucose toxicity and oxidative stress
through TXNIP to downstream activation of the NLRP3 inflam-
masome and secretion of IL-1b (Zhou et al., 2010). Here we
found that the loss of TXNIP prevents b cell apoptosis and dia-
betes caused by ER stress in the Akita mouse. Thus throughl Metabolism 16, 250–264, August 8, 2012 ª2012 Elsevier Inc. 259
Figure 6. ER Stress Leads to IRE1a-Dependent TXNIP Upregulation, NLRP3 Inflammasome Activation, Caspase-1 Cleavage, and IL-1b
Secretion
(A) IL-1b secretion from C57BL/6 murine islets exposed to 1 mM Tg or 33 mM glucose.
(B) IL-1b secretion from human THP-1 cells after 4 hr treatment with DMSO control, 10 mg/ml Tm, 1 mM Tg, or 5 mM ATP as assessed by ELISA.
(C) Caspase-1 cleavage from procaspase-1 in THP_1 cells (detected by immunoblot) in response to ER stress 1 mM Tg (at 2 hr and 4 hr), or 5 mM
ATP at 4 hr.
(D) Caspase-1 cleavage in response to ER stress (1 mM Tg) is abrogated in THP-1 cells lacking the NLRP3 inflammasome (THP1-defNLRP3); compare to THP1-
null positive control cells. Control DAMP, ATP, is at 5 mM.
(E) IL-1b secretion in response to ER stress (1 mM Tg) is abrogated in THP-1 cells lacking the NLRP3 inflammasome (THP1-defNLRP3); compare to THP1-null
positive control cells. Control DAMP ATP is at 5 mM.
(F) STF-083010 blocks IRE1a RNase. Shown is an EtBr-stained agarose gel of XBP1 cDNA amplicons after induction of ER stress for 4 hr in THP-1 cells
using 1 mM Tg, with or without pretreatment with STF-083010 at 50 mM for 2 hr. The cDNA amplicon of unspliced XBP1 mRNA is cleaved by a PstI site within a
26 nt intron to give 2U and 3U. IRE1a-mediated cleavage of the intron and religation in vivo removes the PstI site to give the 1S (spliced) amplicon. * indicates
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Figure 7. IllustrativeModels of Adaptive and
Terminal UPR Signaling
(A) Under remediable levels of ER stress, adaptive
UPR outputs through XBP1 mRNA splicing re-
duces ER stress, in turn closing negative feedback
loops to shut down low-level IRE1a signaling.
(B) Alternatively, under irremediable levels of ER
stress, hyperactivated IRE1a induces TXNIP as a
potentiating step in the terminal UPR, in part
through stabilizing TXNIPmRNAby reducing levels
of a repressive miR that targets TXNIP mRNA. This
event combines with de novo transcription of
TXNIP, through PERK kinase and ChREBP, to
result in rapid elevation of TXNIP mRNA to new
steady-state levels. TXNIP protein activates the
NLRP3 inflammasome, which cleaves procas-
pase-1 to its active form, in turn causing matura-
tion and secretion of interleukin-1b (IL-1b), thus
promoting sterile inflammation and programmed
cell death. Moreoever, ER-localized mRNA decay
by hyperactivated IRE1a (requiring both a func-
tional kinase and RNase activity) furthers—rather
than corrects—ER stress, thus promoting vicious
cycles of cell destruction. Also shown is the RNase
inhibitor—STF-083010—which reduces terminal
UPR endpoints by inhibiting IRE1a RNase activity.
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IRE1a Induces TXNIP, Inflammasome, and Cell Deatha link to the NLRP3 inflammasome, TXNIP may be well-posi-
tioned to mediate both cell autonomous and nonautonomous
destructive responses to diverse DAMPs, including unfolded
proteins in the ER.
IRE1a and PERK are both upstream UPR master kinases
whose activation levels correlate directly with ER unfolded
protein levels. Together, IRE1a and PERK may utilize the levels
and duration of autophosphorylation to control homeostatic-
apoptotic switching. Under low/remediable levels of ER stress,
self-association of IRE1a through its lumenal domain extin-
guishes as adaptive UPR outputs from XBP1s re-establish
homeostasis (Figure 7A). However, under irremediable ER
stress, high-order oligomerization through IRE1a’s lumenal
domains leads to kinase hyperphosphorylation and acquisitiona spliced/unspliced XBP1 hybrid amplicon. The ratio of spliced over (spliced + unspliced) amplicons—1S/(1S
amplicons.
(G and H) STF-083010 blocks TXNIP mRNA upregulation in WT IRE1a-overexpressing INS-1 cells (G) and IL-
response to 5mM ATP is unaffected by STF-083010.
Bar graphs represent three independent biological samples. Data are shown as mean ± SD. **p < 0.005; ns
Cell Metabolism 16, 250–2of relaxed specificity in the RNase. Endo-
nucleolytic destruction of RNAs localizing
to the ER membrane during cotransla-
tional translocation in close proximity to
hyperactive IRE1a RNase occurs under
irremediable ER stress and is mimicked
when overexpressing WT- IRE1a;
instead, forcible activation of IRE1a
(I642G) under 1NM-PP1 more closely
mimics an adaptive UPR, primarily con-
strained to XBP1 splicing. Thus, IRE1a
RNase hyperactivation leading to ER-
localized mRNA decay actually amplifiesand promotes ER stress-mediated cell death (Han et al., 2009)
(Figure S4D). Opposite to its direct effects on destabilizing ER-
localized mRNAs, IRE1a RNase activation may also cleave
specific miRs, and in doing so indirectly stabilize specific
mRNA targets needed to promote cell death. In this scenario,
adaptive outputs through XBP1 mRNA splicing may become
eclipsed and irrelevant as destructive IRE1a signaling dominates
in a terminal UPR (Figure 7B). A therapeutic strategy to shut
down IRE1a RNase entirely should therefore reduce destructive
outputs under irremediable ER stress. Consistent with this
notion, the tool compound STF-083010, which selectively
targets the IRE1a RNase activity (Papandreou et al., 2011),
markedly reduces TXNIP induction and downstream IL-1b
maturation and secretion. We interpret these results as+2U+3U)—is reported as the percent spliced XBP1
1b secretion from THP-1 cells (H); IL-1b secretion in
, not significant. See also Figure S7.
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Cell Metabolism
IRE1a Induces TXNIP, Inflammasome, and Cell Deathproof-of-concept that targeting the hyperactive IRE1a RNase
can disrupt cell destructive endpoints in the terminal UPR. It is
likely that the active component of STF-083010 is the salicylalde-
hyde that rapid hydrolysis of its sulfonylimine unmasks (Volk-
mann et al., 2011). Aldehydes are inherently unstable in vivo
andmay limit the utility of this compound class. The future devel-
opment of more drug-like inhibitors will allow these concepts to
be effectively explored in vivo for amelioration of ER stress
disease endpoints.
For multicellular organisms, the sacrifice of irremediably
stressed cells through programmed cell death is an ultimate
and fail-safe method to ensure protein quality control, and thus
to maintain health. Yet overzealous cell death may cause organ
failure and expose organisms to the risk of cell degenerative
diseases, such as diabetes mellitus. Many cell degenerative
diseases, including diabetes mellitus and some neurodegenera-
tive diseases, are now thought to occur in part from UPR dysre-
gulation. Drug target validation of the IRE1a-TXNIP-IL-1b chain
may ultimately lead to therapeutic advances for such diseases.
EXPERIMENTAL PROCEDURES
Immunoaffinity Purification of Polyribosomal mRNA
INS-1-EGFP or INS-1-EGFP-L10a stable cell lines were induced with Dox,
treated with cycloheximide, washed with PBS, and lysed with 20 mM HEPES
(pH 7.4), 150 mM KCL, 2 M MgCl2, 1% NP-40. Lysates were homogenized in
ice-cold polysome extraction buffer and homogenates clarified. Immunoaffin-
ity purification of polysomal RNA used goat anti-GFP (Nathaniel Heintz, Rock-
efeller University), which was precipitated, resuspended, and quantified for
DNAmicroarray experiments (see the Supplemental Experimental Procedures
for further details).
Chemical-Genetic Cell Lines
INS-1 cells with doxycycline inducible expression of EGFP or EGFP-L10a
fusion were generated from INS-1/FRT/TO cells (Thomas et al., 2004), as
were the previously described IRE1a chemical-genetic variants and XBP1s-
expressing cell lines (Han et al., 2009). See the Supplemental Experimental
Procedures for further details on induction of transgenic proteins.
Detection of IL-1b
Human THP-1 cells were grown in RPMI-1640 media supplemented with 10%
(vol/vol) FBS and 50 mM 2-mercaptoethanol (Sigma #M3148). THP-1 cells
were differentiated for 2 hr with 0.5 mM phorbol-12-myristate-13-acetate
(Sigma #P8139). Differentiated THP-1 cells were primed for 18 hr with ultra-
pure lipopolysaccharide (LPS; 1 mg/ml, Sigma #L5293). THP-1 cell culture
media was changed to media without LPS and treated with ATP (5 mM, Roche
#11162306001), or Tg (1 mM Sigma #T9033) for 4 hr. THP-1 cells were
untreated or treated with 50 mM STF-083010 for 2 hr prior to the addition of
Tg (1 mM) or Tm (10 mg/ml, Sigma #T7765) and allowed to incubate for 4 hr.
After 4 hr, the media supernatant was collected and assayed for hIL-1b by
ELISA (#EH2IL1B from Thermo Scientific). Further variants of THP-1 cells
used in this study were from InvivoGen: THP1-defNLRP3, deficient in
NLRP3; and THP1 Null, which is a positive control line proficient for inflamma-
some function.
Western Blots and Antibodies
For protein analysis, cells were lyzed in 13M-PER buffer (#78501, Pierce) plus
10 U protease inhibitor (#P840 from Sigma) and 250 mM sodium fluoride
(#S299-100, Fisher Scientific). The protein concentration of samples was
determined using a Thermo BCA Assay. Western blots were performed with
the Invitrogen XCell SureLock Mini-Cell and XCell II Blot Module (#EI0002)
plus NuPage 10% (#NP0315BOX) and 12% (#NP0341BOX) Bis-Tris precast
gels. Gels were run with MES buffer (#NP0002) and transferred onto Immobi-
lin-P transfer membrane (IPVH07850 from Millipore) with a XCell II Blot262 Cell Metabolism 16, 250–264, August 8, 2012 ª2012 Elsevier IncModule (#EI9051). See the Supplemental Experimental Procedures for details
on antibodies, dilutions, and detection.
RNA Isolation, Quantitative RT-PCR, and Primers
RNA was isolated from whole cells with either the QIAGEN RNeasy kit
(#74104) or the ZR RNA Mini-prep kit (Zymo Research #R1064). See the
Supplemental Experimental Procedures for details on primer sequences and
quantitative PCR.
Flow Cytometry
For assaying apoptosis by Annexin V staining, cells were plated 2 days prior to
FACS in 6-well plates. The day before flow cytometry, MEFswere inducedwith
either 5 mg/ml Tm or 1 mMTg. The next day, cells were trypsinized and washed
in PBS and resuspended in Annexin V binding buffer with Annexin-V FITC
(#K101-100, Biovision). Flow cytometry was performed on a Becton Dickinson
LSRII flow cytometer.
Animal Studies
C567BL/6 and C57BL/6 Ins2 WT/C96Y were obtained from Jackson Laborato-
ries. Txnip/ mice were generated as previously described (Hui et al.,
2008). Txnip/; Ins2 WT/C96Y mice were generated by breeding of Txnip/
and Ins2 WT/C96Y mice and are both on the C57BL/6 background. All proce-
dures described involving animals were performed in accordance with proto-
cols approved by the Institutional Animal Care and Use Committee at the
University of California, San Francisco. Animals were maintained in a specific
pathogen-free animal facility on a 12 hr light-dark cycle at an ambient temper-
ature of 21C. They were given free access to water and food. All experiments
used age-matched male mice.
Statistical Analysis
To calculate the significance of a difference deviation between two means, we
used two-tailed Student’s t tests. p values are specified in legends for each
figure. Data are shown as mean ± SD.
ACCESSION NUMBERS
The accession number for the microarray data for our work, accepted at GEO
at NCBI, is GSE39212.
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